Plain-English translation of NCT05792007 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand why some children with acute leukemia stop responding to chemotherapy or have their cancer come back. This study collects bone marrow samples from newly diagnosed children with leukemia and compares them to bone marrow from healthy children having orthopedic surgery. By studying the cells that surround leukemia cells in the bone marrow, scientists hope to discover why the leukemia cells become resistant to treatment.
Even with the best chemotherapy available today, some children with leukemia experience relapse or the cancer doesn't respond well to treatment. Researchers believe that cells in the bone marrow microenvironment—the tissue surrounding leukemia cells—may be helping leukemia cells survive and resist treatment. This study aims to uncover those hidden mechanisms so doctors can develop better strategies to overcome treatment resistance.
You likely qualify if…
You likely don't qualify if…
If you join this study, doctors will collect a bone marrow sample from you, typically as part of your standard diagnostic testing for leukemia. The research team will also collect a sample from a healthy child who is having orthopedic surgery. These samples will be studied in the laboratory to compare how the bone marrow cells differ between children with leukemia and healthy children. There is no long-term follow-up or repeated visits required; the main involvement is providing the initial bone marrow sample.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
France